Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoomin Jeon

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 19, 2023
Effectiveness and Safety of Sodium-Glucose Cotransporter 2 Inhibitors Added to Dual or Triple Treatment in Patients with Type 2 Diabetes MellitusYesol Hong, Yoomin Jeon, Yoona Choi, et al.
Drugs in R&D|January 7, 2022
A Randomized, Double-Blind, Placebo- and Active-Controlled, Escalating Single-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Profiles of Subcutaneous Eflapegrastim in Healthy Japanese and Caucasian SubjectsYoomin Jeon, Nora Lee, Seungjae Baek, et al.
Frontiers in Cardiovascular Medicine|October 17, 2022
Factors affecting the changes in antihypertensive medications in patients with hypertensionTae Kyu Chung, Yoomin Jeon, YeSol Hong, et al.
Cancer Medicine|October 30, 2023
Trends in medical care utilization in patients with cancer: An analysis of real-world data in a tertiary hospital in Korea, 2014-2019Jung-Hyun Won, Tae Kyu Chung, Joochul Lee, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 19, 2023
Effectiveness and Safety of Sodium-Glucose Cotransporter 2 Inhibitors Added to Dual or Triple Treatment in Patients with Type 2 Diabetes MellitusYesol Hong, Yoomin Jeon, Yoona Choi, et al.
Drugs in R&D|January 7, 2022
A Randomized, Double-Blind, Placebo- and Active-Controlled, Escalating Single-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Profiles of Subcutaneous Eflapegrastim in Healthy Japanese and Caucasian SubjectsYoomin Jeon, Nora Lee, Seungjae Baek, et al.
Frontiers in Cardiovascular Medicine|October 17, 2022
Factors affecting the changes in antihypertensive medications in patients with hypertensionTae Kyu Chung, Yoomin Jeon, YeSol Hong, et al.
Cancer Medicine|October 30, 2023
Trends in medical care utilization in patients with cancer: An analysis of real-world data in a tertiary hospital in Korea, 2014-2019Jung-Hyun Won, Tae Kyu Chung, Joochul Lee, et al.
Pageof 1